Author/Authors :
Duvall, Janet F National Cancer Institute - National Institutes of Health - USA , Kashanchi, Fatah National Cancer Institute - National Institutes of Health - USA
Abstract :
HTLV-I is the etiologic agent for adult T-cell leukemia/lymphoma (ATL) and HTLV-I- associated myelopathy/tropical spastic paraparesis (HAM/TSP). Taxi, the major activator of this
virus, is a 40- kDa (353 amino acid) phosphoprotein, predominantly localized in the nucleus of
the host cell, which functions to trans-activate both viral and cellular promoters. Recently it has
been shown that HTLV-I and /or Taxl expressing cells have altered gene expression of some of
the cell cycle associated genes. Tax activates HTLV-I as well as number of other cellular
promoters through CREB, NF-kB and SRE elements. In this study we analyzed the effect of a
general coactivator, namely CBP, which may be involved in activation of many cellular genes. To
analyze CBP transcription activation, we have utilized an in vitro transcription assay that allows
the analysis of transcription initiation and reinitiation in the absence of chromatin effects. In
this assay, which utilizes a G-free cassette downstream of the Tax-responsive 21 by repeats, polymerase II molecules responsible for the first round of transcription remain at the end of the
G-free region, effectively blocking the complete elongation of reinitiated transcripts. Addition of
Tax and a 682 amino acid fragment of CBP to the in vitro transcription reactions increased both
full-length and shorter transcripts resulting from reinitiation. A CBP deletion mutant lacking
the N-terminal activation domain was inactive. Preliminary data is also presented to show that,
transactivation of HTLV-I and a cellular promoter, namely cyclin D2, takes place in early
GO/G1 before the restriction point, "R", where Rb function has been implicated.
Keywords :
HTLV-I , Tax , cyclin , transcription